86
Participants
Start Date
November 23, 2015
Primary Completion Date
November 10, 2023
Study Completion Date
November 30, 2025
metformin hydrochloride
given PO
placebo
given PO
Mount Sinai Hospital, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Roswell Park Cancer Institute, Buffalo
Duke University Medical Center, Durham
Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Greenville Health System Cancer Institute-Andrews, Greenville
Prisma Health Cancer Institute - Butternut, Greenville
Prisma Health Cancer Institute - Faris, Greenville
Prisma Health Greenville Memorial Hospital, Greenville
Prisma Health Cancer Institute - Eastside, Greenville
Prisma Health Cancer Institute - Easley, Easley
Prisma Health Cancer Institute - Greer, Greer
Prisma Health Cancer Institute - Seneca, Seneca
Ohio State University Comprehensive Cancer Center, Columbus
The Christ Hospital, Cincinnati
The Community Hospital, Munster
University of Wisconsin Carbone Cancer Center, Madison
Mayo Clinic in Rochester, Rochester
University of Kansas Cancer Center, Kansas City
Cotton O'Neil Cancer Center / Stormont Vail Health, Topeka
University of Oklahoma Health Sciences Center, Oklahoma City
M D Anderson Cancer Center, Houston
Doctor's Hospital of Laredo, Laredo
Los Angeles County-USC Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles
City of Hope Comprehensive Cancer Center, Duarte
City of Hope South Pasadena, South Pasadena
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER